Cigarette smoking is the major cause of
chronic obstructive pulmonary disease. Considerable attention has been paid to the reduced harm potential of
nicotine-containing inhalable products such as electronic cigarettes (e-cigarettes). We investigated the effects of mainstream cigarette
smoke (CS) and e-vapor
aerosols (containing
nicotine and flavor) generated by a capillary
aerosol generator on emphysematous changes, lung function, and molecular alterations in the respiratory system of female
Apoe-/- mice. Mice were exposed daily (3 h/day, 5 days/week) for 6 months to
aerosols from three different e-vapor formulations-(1) carrier (
propylene glycol and vegetable
glycerol), (2) base (carrier and
nicotine), or (3) test (base and flavor)-or to CS from 3R4F reference cigarettes. The CS and base/test
aerosol concentrations were matched at 35 µg
nicotine/L. CS exposure, but not e-vapor exposure, led to impairment of lung function (pressure-volume loop area, A and K parameters, quasi-static elastance and compliance) and caused marked
lung inflammation and emphysematous changes, which were confirmed histopathologically and morphometrically. CS exposure caused lung transcriptome (activation of oxidative stress and inflammatory responses), lipidome, and
proteome dysregulation and changes in DNA methylation; in contrast, these effects were substantially reduced in response to the e-vapor
aerosol exposure. Compared with
sham,
aerosol exposure (carrier, base, and test) caused a slight impact on
lung inflammation and epithelia irritation. Our results demonstrated that, in comparison with CS, e-vapor
aerosols induced substantially lower biological and pathological changes in the respiratory tract associated with chronic
inflammation and
emphysema.